Privacy Policy

Your privacy is important to us. This Privacy Policy explains how we collect, use, and protect your information when you use our website.

Last Updated: September 25, 2026

Information We Collect

We may collect personal information that you voluntarily provide, including:

  • Name

  • Email address

  • Phone number

  • Any information submitted through contact or appointment forms

  • We may also collect non-personal data such as browser type, device information, and pages visited for analytics purposes.

How We Use Your Information

We use the collected information to:

  • Respond to inquiries and requests

  • Provide and improve our services

  • Communicate updates or important information

  • Analyze website performance and user experience

Cookies & Analytics

Our website may use cookies and similar technologies to enhance your browsing experience and analyze traffic. You can choose to disable cookies through your browser settings.

Data Protection

We take reasonable measures to protect your personal information from unauthorized access, disclosure, or misuse. However, no method of transmission over the internet is completely secure.

Third-Party Services


We may use trusted third-party tools (such as analytics or form services) to operate our website. These services only receive the information necessary to perform their functions and are obligated to protect your data.

Your Rights

You have the right to:

  • Request access to your personal data

  • Request correction or deletion of your data

  • Withdraw consent at any time

To exercise these rights, please contact us using the information below.

Children’s Privacy


Our website is not intended for children under the age of 13, and we do not knowingly collect personal information from children.

Changes to This Policy


We may update this Privacy Policy from time to time. Any changes will be posted on this page with an updated revision date.

Contact Us

If you have any questions about this Privacy Policy, please contact us at:

Email: biohybridd@gmail.com

FAQs

Frequently Asked Questions

Frequently Asked Questions

Frequently Asked Questions

What is Bio-Hybrid Therapeutics developing?

Bio-Hybrid Therapeutics is developing biologic medications focused on allergic diseases, including Atopic Dermatitis, Rhinitis, IBS, and anaphylaxis-related allergic reactions.

What is BHT002D™?

BHT002D™ is Bio-Hybrid Therapeutics’ lead patent-pending biologic candidate for Atopic Dermatitis. It is intended to prevent allergic reactive symptoms caused by specific protein allergens.

Is BHT002D™ approved by the FDA?

BHT002D™ is set to begin clinical trials in Summer 2027.

Who is Bio-Hybrid Therapeutics designed to serve?

The primary audience includes healthcare providers, allergists, and immunologists. Secondary audiences include patients with severe or chronic allergic conditions, and tertiary audiences include biotech investors and research institutions.

What makes Bio-Hybrid Therapeutics different?

Bio-Hybrid Therapeutics is focused on prevention, precision, simplicity, and biologic innovation, with a brand voice that balances scientific rigor and human empathy.

The Future of Allergy Relief Starts at the Source

The Future of Allergy Relief Starts at the Source

The Future of Allergy Relief Starts at the Source

Bio-Hybrid Therapeutics is advancing a focused biologic pipeline designed to improve quality of life for people living with allergic diseases. Our immune globulin therapies offers a targeted approach to allergy prevention — built for today’s clinical needs. Connect with our team to learn more about our science, pipeline, and partnership opportunities.

Bio-Hybrid Therapeutics is advancing a focused biologic pipeline designed to improve quality of life for people living with allergic diseases. Our immune globulin therapies offers a targeted approach to allergy prevention — built for today’s clinical needs. Connect with our team to learn more about our science, pipeline, and partnership opportunities.

Bio-Hybrid Therapeutics is advancing a focused biologic pipeline designed to improve quality of life for people living with allergic diseases. Our immune globulin therapies offers a targeted approach to allergy prevention — built for today’s clinical needs. Connect with our team to learn more about our science, pipeline, and partnership opportunities.